VANDA PHARMACEUTICALS INC's ticker is VNDA and the CUSIP is 921659108. A total of 134 filers reported holding VANDA PHARMACEUTICALS INC in Q2 2017. The put-call ratio across all filers is 0.32 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2019 | $328,000 | -50.6% | 20,000 | -60.0% | 0.01% | -61.5% |
| Q3 2019 | $664,000 | -41.1% | 50,000 | -37.5% | 0.01% | -56.7% |
| Q2 2019 | $1,127,000 | -27.9% | 80,000 | -5.9% | 0.03% | -23.1% |
| Q1 2019 | $1,564,000 | -32.0% | 85,000 | -3.4% | 0.04% | -59.4% |
| Q4 2018 | $2,300,000 | +150.5% | 88,000 | +120.0% | 0.10% | +300.0% |
| Q3 2018 | $918,000 | +22.4% | 40,000 | +1.6% | 0.02% | +33.3% |
| Q2 2018 | $750,000 | +11.3% | 39,358 | -1.6% | 0.02% | -14.3% |
| Q1 2018 | $674,000 | -11.3% | 40,000 | -20.0% | 0.02% | +5.0% |
| Q4 2017 | $760,000 | -22.8% | 50,000 | -9.1% | 0.02% | -45.9% |
| Q3 2017 | $985,000 | +4.2% | 55,000 | -5.2% | 0.04% | -7.5% |
| Q2 2017 | $945,000 | +12.5% | 58,000 | -3.3% | 0.04% | +21.2% |
| Q1 2017 | $840,000 | +5.3% | 60,000 | +20.0% | 0.03% | -15.4% |
| Q4 2016 | $798,000 | +299.0% | 50,000 | +316.7% | 0.04% | +225.0% |
| Q3 2016 | $200,000 | +138.1% | 12,000 | +20.0% | 0.01% | +200.0% |
| Q1 2016 | $84,000 | -27.6% | 10,000 | -20.0% | 0.00% | -50.0% |
| Q4 2015 | $116,000 | -17.7% | 12,500 | 0.0% | 0.01% | +33.3% |
| Q3 2015 | $141,000 | -68.2% | 12,500 | -64.3% | 0.01% | -66.7% |
| Q2 2015 | $444,000 | +2.8% | 35,000 | -24.6% | 0.02% | -5.3% |
| Q1 2015 | $432,000 | -39.7% | 46,400 | -7.2% | 0.02% | -24.0% |
| Q4 2014 | $716,000 | +6.1% | 50,000 | -23.1% | 0.02% | +56.2% |
| Q3 2014 | $675,000 | -44.4% | 65,000 | -13.3% | 0.02% | -38.5% |
| Q2 2014 | $1,214,000 | +54.5% | 75,000 | +55.1% | 0.03% | +62.5% |
| Q1 2014 | $786,000 | +5.5% | 48,360 | -19.4% | 0.02% | 0.0% |
| Q4 2013 | $745,000 | -15.0% | 60,000 | -25.0% | 0.02% | +77.8% |
| Q3 2013 | $876,000 | +8.4% | 80,000 | -20.0% | 0.01% | -62.5% |
| Q2 2013 | $808,000 | – | 100,000 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Signpost Capital Advisors, LP | 1,688,952 | $27,327,000 | 10.37% |
| Palo Alto Investors LP | 3,240,424 | $52,430,000 | 3.90% |
| Parametrica Management Ltd | 12,509 | $202,000 | 1.53% |
| KINGDON CAPITAL MANAGEMENT, L.L.C. | 1,740,400 | $28,160,000 | 1.08% |
| PACIFIC ALTERNATIVE ASSET MANAGEMENT COMPANY, LLC | 557,100 | $9,014,000 | 1.07% |
| Westend Capital Management, LLC | 64,086 | $841,000 | 1.00% |
| WALL STREET ASSOCIATES | 702,700 | $11,370,000 | 0.98% |
| Baker Brothers Advisors | 4,372,153 | $70,741,000 | 0.87% |
| Iguana Healthcare Management, LLC | 100,000 | $1,618,000 | 0.76% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 1,085,301 | $17,560,000 | 0.71% |